SCHEMBL4267030

SCHEMBL4267030

CCCC(C)N=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14614830 1.00
SCHEMBL13073778 1.00
SCHEMBL18556498 0.83 ALDH1A1 (0.35)
SCHEMBL24080860 0.82
SCHEMBL14472645 0.82
SCHEMBL4273508 0.82
SCHEMBL14207168 0.80
SCHEMBL14040440 0.80 CA2 (0.31)
SCHEMBL8003727 0.78 OPRM1 (0.44)
SCHEMBL12652162 0.78 OPRM1 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3651002-B1 DISPLAY DEVICE LG DISPLAY CO LTD (KR) 2023-06-28 EP disclosed
EP-2970316-B1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF HYDRA BIOSCIENCES INC (US) 2017-11-08 EP disclosed
US-20170167270-A1 ARTICLE AND METHOD OF FORMING AN ARTICLE GE INFRASTRUCTURE TECHNOLOGY LLC 2017-06-15 US disclosed
WO-2017004436-A2 A THERAPEUTIC SYSTEM COMPRISING PHARMACEUTICALS IN COMBINATION WITH METABOLIC ENHANCEMENT FOR NEURODEGENERATION THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-01-05 WO disclosed
CN-106103404-A The preparation of biphenol compound and application 迈克斯(如东)化工有限公司 2016-11-09 CN disclosed
US-20160137735-A1 METHOD OF TREATING MULTIPLE MYELOMA USING COMBINATION THERAPIES BASED ON ANTI-CS1 ANTIBODIES ABBVIE BIOTHERAPEUTICS INC (US) 2016-05-19 US disclosed
US-9045465-B1 3-heterocyclyl-substituted benzoyl derivatives BASF SE (DE) 2015-06-02 US disclosed
US-20140322201-A1 METHODS OF TREATING MULTIPLE MYELOMA USING COMBINATION THERAPIES BASED ON ANTI-CS1 ANTIBODIES ABBVIE BIOTHERAPEUTICS INC (US) 2014-10-30 US disclosed
US-8215762-B2 Recording apparatus that forms ink receiving layer(s) on an intermediate transfer body and recording method thereof FUJI XEROX CO., LTD. (JP) 2012-07-10 US disclosed
US-20110156229-A1 SEMICONDUCTOR DEVICE AND MANUFACTURING METHOD THEREFOR RENESAS ELECTRONICS CORPORATION 2011-06-30 US disclosed
US-7354806-B2 Semiconductor device structure with active regions having different surface directions and methods INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2008-04-08 US disclosed
US-7344686-B2 Desulfurization apparatus with individually controllable heaters MESOSCOPIC DEVICES, INC. (US) 2008-03-18 US disclosed
US-20080039327-A1 Herbicide; in crops such as wheat, rice, maize, soybeans and cotton they act against broad-leaved weeds and grass weeds without damaging the crop plants; compounds are based on 3-(5,5-disubstituted 2-isoxazolin-3-yl)benzoic acid, esters, thioesters and pyrazolyl ketones thereof DEYN WOLFGANG V 2008-02-14 US disclosed
US-20070163966-A1 Food processing effluent refurbishing system and method ECOLAB INC. (US) 2007-07-19 US disclosed
US-7232792-B2 3-heterocyclyl-substituted benzoyl derivatives BASF AKTIENGESELLSCHAFT (DE) 2007-06-19 US disclosed
US-20070042236-A1 Modular fuel cell power system, and technique for controlling and/or operating same FUEL CELL POWER, INC. 2007-02-22 US disclosed
US-20070017291-A1 MONITORING AND CONTROLLING UNIT OPERATIONS SYMYX TECHNOLOGIES, INC. (US) 2007-01-25 US disclosed
US-20020025910-A1 3-heterocycly1 - substituted benzoyl derivatives DEYN WOLFGANG VON (DE) 2002-02-28 US disclosed
EP-0958291-A1 3-HETEROCYCLYL-SUBSTITUTED BENZOYL DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 1999-11-24 EP disclosed
WO-1998031681-A1 3-HETEROCYCLYL-SUBSTITUTED BENZOYL DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 1998-07-23 WO disclosed